# Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

> **NCT00401778** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 33 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** RAD001

## Key facts

- **NCT ID:** NCT00401778
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2016-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401778, "Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00401778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*